Major updates in the biotech sector over the past four trading days were on the pipeline and regulatory front from companies like Alkermes (ALKS – Analyst Report) and Amgen (AMGN – Analyst Report) among others.Recap of the Week’s Most Important Stories1. Alkermes’ experimental schizophrenia treatment, ALKS 3831, fared well in a mid-stage study. Earlier this year, the company had said […]
Related CLDXWhy Cowen & Co Likes Celldex Therapeutics Following Its FDA ‘Breakthrough’Biotech Stocks Moving HigherCelldex Therapeutics(Investor’s Business Daily)Related BLRXMorning Market GainersBenzinga’s Top #PreMarket GainersRoth Capital Weighs In On 5 Biotech Stocks To Watch(Seeking Alpha)As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.”Though […]
Once again, acquisition news made it to the headlines with Horizon Pharma (HZNP – Snapshot Report) announcing that it will be acquiring Hyperion Therapeutics (HPTX – Snapshot Report). BioMarin has hit a 52-week high on acquisition rumors. Meanwhile, it’s been an eventful week on the pipeline and regulatory front as well with companies like Conatus (CNAT – Snapshot Report), Amgen […]
Posted by Jason Zweig on Mar 30, 2015 in Blog, Featured, Posts |Image credit: Genetically modified Amflora cells, BASF, flickr Creative CommonsBy Jason Zweig11:17 am ET Mar. 27, 2015In a research note out today, Credit Suisse analysts Ravi Mehrotra, Jason Kantor, Anuj Shah and Jeremiah Shepard write that biotechnology stocks are not in a bubble but “rather in a new […]
Wikimedia CommonsThere is probably a bubble in biotech stocks. In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what it […]
Akin Oyedele
Mar. 27, 2015, 8:54 AM
542
Wikimedia CommonsCredit Suisse analysts say biotechs are not in a bubble.Still, in a note Friday, the firm presents evidence for the industry being in in a bubble, and other evidence that it definitely isn’t.The signs that there’s a bubble, they wrote, are that the NYSE Biotech Index has gained 204% versus 64% for the S&P 500 since […]
Wikimedia CommonsSee AlsoAviation tracking service: Germanwings co-pilot set autopilot to the lowest possible settingFed market gurus prep rate hike amid last-minute anxietiesWe just found out who the third American was on the crashed Germanwings flightNEW YORK (Reuters) – A 4 percent decline in biotechnology stocks on Wednesday sent the Nasdaq Composite Index to its largest one-day loss in nearly a […]
Akin Oyedele
Mar. 26, 2015, 8:22 AM
1,134
Wikimedia CommonsSome investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
